Learn More
Medchemexpress LLC Dosimertinib-d5 mesylate | 2403760-72-3 | 99.4% | 600.74 g·mol⁻1 | C29H32D5N7O5S | 5 MG

Supplier: Medchemexpress LLC HY142283AS5MG
Dosimertinib-d5 mesylate is the deuterated mesylate salt of an EGFR inhibitor intended for preclinical research. It is reported to reduce phosphorylation of EGFR and ERK, show antiproliferative and antitumor activity in model systems, and is used in studies of non-small-cell lung cancer and EGFR signaling pathways.
- Deuterated small molecule designed for EGFR pathway research.
- Mesylate salt form with improved handling and solubility characteristics.
- Demonstrated decrease in p-EGFR and p-ERK levels in vitro.
- Shows antiproliferative and antitumor activity in preclinical models.
- Supplied in a 5 mg package suitable for analytical and in vitro studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.